Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study is to compare the exposure of orally administered Prodarsan to the intravenous
dosed Osmitrol (10% solution) in Cockayne Syndrome (CS) patients. Also the pharmacokinetics
of single and multiple orally dosed Prodarsan will be evaluated and compared to intravenous
dose of Osmitrol in CS patients.